Company intelligence / Profile preview

Clinakos

San Mateo, California, United Statesclinakos.com ↗

Ownership: Private
Development stage: Other

Overview

Clinakos provides advanced real-world patient data integration and AI-driven analytics to support life science companies across clinical development, medical affairs/HEOR, commercial launch support, patient journey mapping, adherence analysis, and more. Their proprietary platforms enable high-fidelity insights especially valuable in rare disease and oncology settings. They are not a drug developer but serve as an enabling technology/data partner for biopharma clients.

Therapeutic areas: OncologyRare Diseases
Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Empowers some of the largest life science companies and provider organizations; specific partners not named but includes Fortune 100 pharma clients.

Beyond the preview

Go deeper on Clinakos.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Clinakos.

Explore the full profile